Clin2
NCT07869940Possibly a fitRecruiting

Study of RBD2080 for healthy people

Healthy

This study tests a new medicine called RBD2080 in healthy volunteers to see if it is safe and how the body handles it. It may help in future treatments, but isn't expected to benefit you directly.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are between 18 and 50 years old.
  • You are generally healthy, without significant medical conditions.
  • Your body mass index (BMI) is between 18 and 32.
  • You are willing to get certain vaccines (for meningitis, pneumonia, and Hib) before the study.
  • You do not have any recent infections, surgeries, or major health events in the last 4 weeks.
  • You have no large tattoos or scarring on typical injection areas (like arms or stomach).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch
NCT07699120Enrolling by invitation· Phase 1
Testing BRC-002 safety in healthy volunteers

This trial checks how safe BRC-002 is in healthy people and how it affects the body with and without food. It helps researchers understand the right dose and any side effects.

Toronto, Ontario
NCT06995326Not yet recruiting· Phase 1
Study of an experimental medicine in healthy volunteers

This trial tests a new medicine in healthy people to see how safe it is and how the body handles it. It may help pave the way for future treatments.

NCT07528053Not yet recruiting· Phase 1
Testing an investigational medicine in healthy volunteers

This trial tests a new medication (called BW-20805-2-1001) in healthy volunteers to see if it is safe and how the body handles it. It may help in developing future treatments for certain diseases, though it's not yet known if it will benefit you directly.

Melbourne, Victoria
NCT07526116Recruiting· Phase 1
Safety study of REGN22044 in healthy adults

This is an early-stage safety study testing a new experimental drug called REGN22044 in people with no serious health conditions. Researchers want to understand how safe the drug is, how well people tolerate it, and how the body processes it.

Ghent, Oost-Vlaanderen
NCT07241910Recruiting· Phase 1
Testing the safety of SYH2061 in healthy volunteers

This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.

Hefei, Anhui

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.